Summary:
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE SAFETY, TOLERABILITY, PHARMACOKINETICS OF K0706: AT MULTIPLE ASCENDING DOSE IN SUBJECTS WITH PARKINSON’S DISEASE
Qualified Participants Must:
Be Male or Female aged 18 to 75 years of age
Qualified Participants May Receive:
Compensation for time and travel